AC Immune SA - SHS (ACIU)

Historical Portfolio Holders from Q3 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SHS
Shares, excl. options Q3 2024
28.2M
Holdings value Q3 2024
$107M
Value change Q3 2024
-$1.85M
Grand Portfolio weight change Q3 2024
0%
Number of holders
43
Number of buys Q3 2024
13
Number of sells Q3 2024
-25
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 28.2M $107M -$1.85M $3.78 44
2024 Q2 28.6M $114M -$1.28M $3.99 45
2024 Q1 29M $85.7M -$2.97M $2.96 37
2023 Q4 29.6M $148M +$66.3M $5.00 34
2023 Q3 16M $45.5M -$163K $2.85 28
2023 Q2 16M $47.4M +$6.28M $2.96 33
2023 Q1 14.1M $33M -$1.22M $2.34 32
2022 Q4 14.8M $30.1M +$1.54M $2.04 36
2022 Q3 14M $44.3M +$517K $3.16 32
2022 Q2 13.8M $49.8M -$1.93M $3.61 32
2022 Q1 14.3M $57.2M -$3.46M $4.00 36
2021 Q4 15M $74.5M -$21.8M $4.95 45
2021 Q3 17.7M $118M -$4.03M $6.71 66
2021 Q2 18.2M $144M +$814K $7.93 58
2021 Q1 18.2M $139M -$11.1M $7.61 51
2020 Q4 19.8M $102M -$3.66M $5.17 46
2020 Q3 20.7M $101M +$1.42M $4.88 48
2020 Q2 20.4M $137M +$1.37M $6.73 39
2020 Q1 20.2M $139M +$7.08M $6.91 47
2019 Q4 19.1M $163M +$3.26M $8.52 48
2019 Q3 18.8M $93M +$3.3M $4.95 36
2019 Q2 18.1M $100M +$1.56M $5.55 39
2019 Q1 17.9M $90.6M -$29.3M $5.05 39
2018 Q4 20.2M $191M +$11.5M $9.45 38
2018 Q3 19.1M $153M +$63.5M $8.00 32
2018 Q2 11M $102M -$2.77M $9.31 15
2018 Q1 11.3M $117M +$936K $10.34 18
2017 Q4 11.2M $143M +$18.3M $12.80 21
2017 Q3 9.74M $110M -$3.31M $11.24 15
2017 Q2 10.3M $90.4M -$2.13M $8.80 17
2017 Q1 10.5M $109M +$17.8M $10.36 19
2016 Q4 8.75M $113M +$8.28M $12.98 19
2016 Q3 8.24M $131M +$131M $16.47 32